Lipoprotein(a): A missing culprit in the management of athero-thrombosis? (Q39368804)

11 September 2017

1 reference

title

Lipoprotein(a): A missing culprit in the management of athero-thrombosis? (English)

1 reference

11 September 2017

0 references

0 references

1 reference

5

1 reference

11 September 2017

Tiziana Bacchetti

2

0 references

Maciej Banach

object named as

Maciej Banach

series ordinal

4

0 references

Amirhossein Sahebkar

series ordinal

6

object named as

Amirhossein Sahebkar

1 reference

11 September 2017

Gianna Ferretti

1

1 reference

11 September 2017

Thomas P Johnston

series ordinal

3

1 reference

11 September 2017

publication date

13 June 2017

1 reference

Journal of Cellular Physiology

11 September 2017

published in

1 reference

Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes).

11 September 2017

cites work

1 reference

The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis.

21 January 2018

1 reference

Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site.

21 January 2018

1 reference

The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor

21 January 2018

1 reference

Prediction of cardiovascular events in statin-treated stable coronary patients of the treating to new targets randomized controlled trial by lipid and non-lipid biomarkers

21 January 2018

1 reference

A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma

21 January 2018

1 reference

Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?

21 January 2018

1 reference

Lipoprotein [a] is cleared from the plasma primarily by the liver in a process mediated by apolipoprotein [a].

21 January 2018

1 reference

Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease

21 January 2018

1 reference

Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis

21 January 2018

1 reference

Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy

21 January 2018

1 reference

Genetic variants associated with Lp(a) lipoprotein level and coronary disease

21 January 2018

1 reference

LPA and PLG sequence variation and kringle IV-2 copy number in two populations

21 January 2018

1 reference

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

21 January 2018

1 reference

The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein

21 January 2018

1 reference

First WHO/IFCC International Reference Reagent for Lipoprotein(a) for Immunoassay--Lp(a) SRM 2B

21 January 2018

1 reference

Lipoprotein (a): impact by ethnicity and environmental and medical conditions

21 January 2018

1 reference

Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality

21 January 2018

1 reference

Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants

21 January 2018

1 reference

Raloxifene Lowers Plasma Lipoprotein(a) Concentrations: a Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials

21 January 2018

1 reference

Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myo

21 January 2018

1 reference

Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia

21 January 2018

1 reference

Subclinical hypothyroidism and lipid abnormalities in older women attending a vascular disease prevention clinic: effect of thyroid replacement therapy

21 January 2018

1 reference

Effect of Alirocumab on Lipoprotein(a) Over ≥1.5 Years (from the Phase 3 ODYSSEY Program).

21 January 2018

1 reference

Definition of the structural elements in plasminogen required for high-affinity binding to apolipoprotein(a): a study utilizing surface plasmon resonance

21 January 2018

1 reference

Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial

21 January 2018

1 reference

Lipoprotein(a) promotes smooth muscle cell proliferation and dedifferentiation in atherosclerotic lesions of human apo(a) transgenic rabbits

21 January 2018

1 reference

Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin).

21 January 2018

1 reference

Prevention of cardiovascular complications in patients with Lp(a)-hyperlipoproteinemia and progressive cardiovascular disease by long-term lipoprotein apheresis according to German national guidelines

21 January 2018

1 reference

Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia

21 January 2018

1 reference

Tibolone decreases Lipoprotein(a) levels in postmenopausal women: A systematic review and meta-analysis of 12 studies with 1009 patients

21 January 2018

1 reference

Significant impact of the 93 C/T polymorphism in the apolipoprotein(a) gene on Lp(a) concentrations in Africans but not in Caucasians: confounding effect of linkage disequilibrium

21 January 2018

1 reference

Lipoprotein(a) in renal disease

21 January 2018

1 reference

Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis

21 January 2018

1 reference

Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia

21 January 2018

1 reference

Lipoprotein apheresis in patients with maximally tolerated lipid-lowering therapy, lipoprotein(a)-hyperlipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter study

21 January 2018

1 reference

Ox-Lp(a) transiently induces HUVEC autophagy via an ROS-dependent PAPR-1-LKB1-AMPK-mTOR pathway

21 January 2018

1 reference

Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease.

21 January 2018

1 reference

Lipoprotein(a): from ancestral benefit to modern pathogen?

21 January 2018

1 reference

A Polymorphism in the Protease-Like Domain of Apolipoprotein(a) Is Associated With Severe Coronary Artery Disease

21 January 2018

1 reference

Role of tissue factor in hemostasis, thrombosis, and vascular development

21 January 2018

1 reference

Lipoprotein(a) in cardiovascular diseases

21 January 2018

1 reference

Lipoprotein (a) measurements for clinical application

21 January 2018

1 reference

Lipoprotein(a) concentration and apolipoprotein(a) size: A synergistic role in advanced atherosclerosis?

21 January 2018

1 reference

Evaluation of lipoprotein(a) as a prothrombotic factor: progress from bench to bedside

21 January 2018

1 reference

Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: recent advances and future directions

21 January 2018

1 reference

Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study

21 January 2018

1 reference

Lipoprotein(a): Its relevance to the pediatric population

21 January 2018

1 reference

Association of serum oxidized lipoprotein(a) concentration with coronary artery disease: potential role of oxidized lipoprotein(a) in the vasucular wall

21 January 2018

1 reference

IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans

21 January 2018

1 reference

Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy

21 January 2018

1 reference

Lipoprotein(a) as a cardiovascular risk factor: current status

21 January 2018

1 reference

Autotaxin interacts with lipoprotein(a) and oxidized phospholipids in predicting the risk of calcific aortic valve stenosis in patients with coronary artery disease.

21 January 2018

1 reference

Molecular basis of congenital lp(a) deficiency: a frequent apo(a) 'null' mutation in caucasians

21 January 2018

1 reference

A common nonsense mutation in the repetitive Kringle IV-2 domain of human apolipoprotein(a) results in a truncated protein and low plasma Lp(a).

21 January 2018

1 reference

The apolipoprotein(a) component of lipoprotein(a) stimulates actin stress fiber formation and loss of cell-cell contact in cultured endothelial cells

21 January 2018

1 reference

Lipoprotein(a) and inflammation: A dangerous duet leading to endothelial loss of integrity

21 January 2018

1 reference

PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role

21 January 2018

1 reference

Inhibition of plasminogen activation by apo(a): role of carboxyl-terminal lysines and identification of inhibitory domains in apo(a).

21 January 2018

1 reference

Lipoprotein(a) catabolism is regulated by proprotein convertase subtilisin/kexin type 9 through the low density lipoprotein receptor

21 January 2018

1 reference

Effect of extended-release niacin on plasma lipoprotein(a) levels: A systematic review and meta-analysis of randomized placebo-controlled trials

21 January 2018

1 reference

Comparison of the effects of fibrates versus statins on plasma lipoprotein(a) concentrations: a systematic review and meta-analysis of head-to-head randomized controlled trials

21 January 2018

1 reference

New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes

21 January 2018

1 reference

Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia

21 January 2018

1 reference

Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: results of 4 phase III trials

21 January 2018

1 reference

Lipoprotein (a). Heterogeneity and biological relevance

21 January 2018

1 reference

Recycling of Apolipoprotein(a) After PlgRKT-Mediated Endocytosis of Lipoprotein(a).

21 January 2018

1 reference

Lipoprotein (a) and venous thromboembolism in adults: a meta-analysis

21 January 2018

1 reference

Lipoprotein(a) Enhances the Expression of Intercellular Adhesion Molecule-1 in Cultured Human Umbilical Vein Endothelial Cells

21 January 2018

1 reference

Oxidized Phospholipids on apoB-100-Containing Lipoproteins: a Biomarker Predicting Cardiovascular Disease and Cardiovascular Events

21 January 2018

1 reference

A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies

21 January 2018

1 reference

Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease

21 January 2018

1 reference

New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease

21 January 2018

1 reference

Contribution of apolipoprotein(a) size, pentanucleotide TTTTA repeat and C/T( 93) polymorphisms of the apo(a) gene to regulation of lipoprotein(a) plasma levels in a population of young European Caucasians

21 January 2018

1 reference

Long term statin treatment reduces lipoprotein(a) concentrations in heterozygous familial hypercholesterolaemia

21 January 2018

1 reference

Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials

21 January 2018

1 reference

Absolute quantification of apolipoproteins and associated proteins on human plasma lipoproteins.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCP.26050

1 reference

11 September 2017

1 reference